Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.5020
+0.0012 ( -1.57% ) 140.8K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.5020
Previous close
$0.5008
Volume
140.8K
Market cap
$79.49M
Day range
$0.4670 - $0.5200
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Nov 21, 2024 |
| 10-q | Quarterly Reports | 64 | Nov 14, 2024 |
| 8-k | 8K-related | 14 | Nov 08, 2024 |
| 4 | Insider transactions | 1 | Nov 07, 2024 |
| 4 | Insider transactions | 1 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Nov 06, 2024 |
| 3 | Insider transactions | 1 | Nov 05, 2024 |
| 3 | Insider transactions | 1 | Oct 31, 2024 |
| 3 | Insider transactions | 1 | Oct 29, 2024 |